Cargando…
The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases
Immune-mediated inflammatory diseases (IMIDs), such as inflammatory bowel diseases and inflammatory arthritis (e.g., rheumatoid arthritis, psoriatic arthritis), are marked by increasing worldwide incidence rates. Apart from irreversible damage of the affected tissue, the systemic nature of these dis...
Autores principales: | Anchang, Charles Gwellem, Xu, Cong, Raimondo, Maria Gabriella, Atreya, Raja, Maier, Andreas, Schett, Georg, Zaburdaev, Vasily, Rauber, Simon, Ramming, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306614/ https://www.ncbi.nlm.nih.gov/pubmed/34299122 http://dx.doi.org/10.3390/ijms22147506 |
Ejemplares similares
-
P056: Variants of the transcription factor ONECUT2 regulate gene expression in Hodgkin Lymphoma cells
por: Lein, Patricia, et al.
Publicado: (2022) -
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
por: Simon, David, et al.
Publicado: (2021) -
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
por: Simon, David, et al.
Publicado: (2020) -
Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
por: Lamprecht, Georg, et al.
Publicado: (2015) -
Student-led clinics and ePROs to accelerate diagnosis and treatment of patients with axial spondyloarthritis: results from a prospective pilot study
por: von Rohr, Sophie, et al.
Publicado: (2023)